BenzingaOctober 21, 2026 at 4:49 AM NY6 Days Ago
Barclays Maintains Overweight on AbbVie, Raises Price Target to $325
Barclays analyst Emily Field maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $300 to $325.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
